New York, NYNCT05675527Now EnrollingIRB Ready

Shoulder Osteoarthritis Clinical Trial in New York, NY

Access cutting-edge shoulder osteoarthritis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Hospital for Special Surgery, New York

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access shoulder osteoarthritis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related shoulder osteoarthritis treatment provided free

Apply for This New York Location

Check if you qualify for this shoulder osteoarthritis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Shoulder Osteoarthritis Study in New York

The glenohumeral joint is the third most common large joint to be affected by OA. Conservative treatments include physical activity, corticosteroid injections, and medications. PRP is an emerging treatment that has shown efficacy in different musculoskeletal conditions. The use of PRP for glenohumeral OA has been described sparingly in the literature but has shown efficacy in a couple studies and case reports. However, all of the previous studies investigating PRP for glenohumeral OA have focused on low-dose PRP preparations (\~3X), and none have compared PRP treatment to saline treatment. This study aims to compare outcomes following single injections of low-dose PRP, high-dose PRP, or saline in patients with glenohumeral osteoarthritis.

Sponsor: Hospital for Special Surgery, New York

Who Can Participate

Inclusion Criteria

18-100 years old
Average NRS pain greater than or equal to 5/10 as a direct result of glenohumeral osteoarthritis (any severity: mild, moderate, or severe) and/or chondral lesion or loss
At least 3 months of pain after onset of symptoms that has failed conservative treatments, including physical therapy
MRI of the affected joint
Transient relief of symptoms after a diagnostic intra-articular injection into the joint
Email address or network access

Exclusion Criteria

Inability to hold non-steroidal anti-inflammatory drugs for 2 weeks prior and 1 month after the injection
Prior platelet-rich plasma injection
Steroid injection within 3 months of the initial injection
Hyaluronic acid within 6 months of the initial injection
Involved in workers' compensation or active litigation involving the affected joint
History of Plavix use
Known uncontrolled systemic illness (uncontrolled diabetes, HIV, vasculitis, autoimmune/autoinflammatory disease)
Presence of acute fractures or gross mechanical deformities
Concurrent "uncontrolled" cervical disorders

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT05675527) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Shoulder Osteoarthritis Treatment Options in New York, NY

If you're searching for shoulder osteoarthritis treatment options in New York, NY, this clinical trial (NCT05675527) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced shoulder osteoarthritis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all shoulder osteoarthritis clinical trials near you to find additional studies recruiting in your area.

More Osteoarthritis Trials in New York, NY

See all osteoarthritis clinical trials recruiting in New York — not just this study.

Browse Osteoarthritis Trials in New York

Browse More Trials by Condition

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY